6-K ·Filed Apr 16, 2026

EVAX

Evaxion A/S
NEUTRAL
Impact 3/10
Horizonmonths Processed5mo ago SEC0001171843-26-002509
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading implications. Investors should await upcoming clinical or financial updates for material developments.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
EVAX ▼ -27.05% at T+60d
NEUTRAL call ✗ call lost -27.05% · α vs SPY -34.10% · entry $4.14 → $3.02
Entry anchored
Apr 16, 10:20 AM ET
via exchange tick
T+1d
+7.49%
call +7.49% · α +6.27%
$4.45
settled 6mo ago
T+5d
+2.66%
call +2.66% · α +1.67%
$4.25
settled 5mo ago
T+20d
+0.48%
call +0.48% · α -5.33%
$4.16
settled 5mo ago
T+60d
-27.05%
call -27.05% · α -34.10%
$3.02
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Evaxion A/S held its Annual General Meeting on April 16, 2026, approved the 2025 Annual Report, and re-elected four directors while electing one new board member. This is a routine corporate governance update with no material financial implications.

Key Facts

  • Annual General Meeting held on April 16, 2026
  • 2025 Annual Report approved
  • Marianne Sgaard, Lars Holtug, Lars Aage Staal Wegner, and Roberto Prego Pineda re-elected to Board of Directors
  • Jens Bitsch Nrhave elected as new Board member

Financial Impact

No financial impact disclosed

Risk Factors

  • Board composition changes could influence strategic direction over time
  • No new financial or operational data provided in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-002509
Exhibit: exh_991.htm0001171843-26-002509
Document: 0001171843-26-002509-index-headers.html0001171843-26-002509
Document: 0001171843-26-002509-index.html0001171843-26-002509
Document: 0001171843-26-002509.txt0001171843-26-002509
36 reports for EVAX
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+5▲ +22.94%Mar 5, 2026
Filters
Rows
Reports for EVAX — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$3.07 $3.21▲ +4.56%▲ +4.45%$3.22 (+4.89%)
Sep 4, 2026
28d ago
6-K
BEARISH ★ 5/10
$3.12 $3.07▲ +1.60%▲ +0.39%$3.22 (−3.21%)
Aug 20, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$3.28 $3.15▼ −3.96%▼ −5.08%$3.22 (−1.83%)
Aug 20, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$3.28 $3.15▼ −3.96%▼ −5.08%$3.22 (−1.83%)
Aug 17, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$3.13 $3.40▲ +8.63%▲ +9.82%$3.22 (+2.88%)
Aug 14, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$3.34 $3.31▼ −0.90%▲ +0.47%$3.22 (−3.59%)
Aug 14, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$3.34 $3.31▼ −0.90%▲ +0.47%$3.22 (−3.59%)
Jul 17, 2026
11w ago
6-K
BULLISH ★ 7/10
$3.08 $3.05▼ −0.81%▼ −0.13%$3.22 (+4.72%)
Jul 17, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$3.08 $3.05▼ −0.81%▼ −0.13%$3.22 (+4.72%)
Jul 13, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$3.02 $3.08▲ +1.82%▲ +2.61%$3.22 (+6.62%)
Showing 10 of 36

US Market Status

Market Open — Closes in 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access